Bacterial infection in endometriosis: a silver-lining for the development of new non-hormonal therapy?

This article focuses on the potential role of bacterial infection, particularly Fusobacterium species, in the pathogenesis and progression of endometriosis, a condition characterized by the presence of endometrial tissue outside the uterus. It highlights a recent study demonstrating that Fusobacterium infection promotes endometriotic lesion development through immune modulation involving M2 macrophages, transforming growth factor-β1 (TGF-β1), and transgelin expression, and that broad-spectrum antibiotics reduced lesion size in a mouse model. The article also discusses the broader context of microbiota involvement in endometriosis, the challenges in distinguishing whether bacterial infection is a cause or consequence of the disease, and the emerging possibility of antibiotics as a non-hormonal therapeutic option. However, it emphasizes that further research is needed to clarify temporal relationships, therapeutic efficacy in humans, and the complex interactions between bacterial populations and endometriosis.